Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Gastroenterology. 2020 Nov 28;160(2):538–555. doi: 10.1053/j.gastro.2020.10.058

Table 1:

Summary of main findings from gut microbiota composition studies in IBS

Microbiota
variable
IBS
subtype
Summary of finding References
Alpha diversity Both Reduced in cross-sectional samples or samples with high symptom severity 16, 18, 20, 21
Microbiota stability IBS-C Larger temporal variability of fecal community than healthy control samples 18
Proteobacteria Both Elevated in mucosal community from biopsy samples 18, 19
Streptococci Both Elevated in fecal community, positively associated with high symptom severity 16-18
Ruminococci Both Elevated in phylogenetic microarray studies, but not reported in sequencing studies 19, 89
Lachnospiraceae Both Elevated in fecal community, implicated in reduced fecal hypoxanthine levels 16, 18, 90, 91
Methanobrevibacter smitthii Both Functionally implicated in constipation but differentially abundant in very few sequencing studies 89
Alistipes Both Bile tolerant bacteria, have been associated to pain 19